Showing results (111-120 of 507) with videos related to
Sort By:
Pageof 51
Biotechniques|November 21, 2000
Detection of the level of estrogen receptor and functional variants in human breast cancers by novel assaysD K Biswas, A P Cruz, A B PardeeMutation Research|February 1, 1984
Comparative analysis of caffeine and 3-aminobenzamide as DNA repair inhibitors in Syrian baby hamster kidney cellsS K Das, C C Lau, A B PardeeThe Journal of Biological Chemistry|July 15, 1993
The thymidylate synthase inhibitor, ICI D1694, overcomes translational detainment of the enzymeK Keyomarsi, J Samet, G Molnar, et al.Cancer Research|October 23, 1997
Re-expression of elafin in 21MT2 breast carcinomas by phorbol 12-myristate 13-acetate is mediated by the Ap1 site in the elafin promoterM Zhang, D Magit, A B Pardee, et al.Cancer Research|July 1, 1991
Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatinK Keyomarsi, L Sandoval, V Band, et al.Cancer Research|February 1, 1989
Inhibition of potentially lethal DNA damage repair in human tumor cells by beta-lapachone, an activator of topoisomerase ID A Boothman, D K Trask, A B PardeeProceedings of the National Academy of Sciences of the United States of America|December 1, 1987
Cell-cycle-specific interaction of nuclear DNA-binding proteins with a CCAAT sequence from the human thymidine kinase geneG B Knight, J M Gudas, A B PardeeProceedings of the National Academy of Sciences of the United States of America|August 1, 1979
Loss of epidermal growth factor requirement and malignant transformationP V Cherington, B L Smith, A B PardeeNucleic Acids Research|August 25, 1995
Quantification of DNA-protein interaction by UV crosslinkingG Molnar, N O'Leary, A B Pardee, et al.Molecular Medicine (Cambridge, Mass.)|July 28, 2001
Potent induction of apoptosis by beta-lapachone in human multiple myeloma cell lines and patient cellsY Li, C J Li, D Yu, et al.Pageof 51